Clinical trials in Ruse – page 13

184 clinical trials in Ruse, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ruse at a glance

184

clinical trials

Research sites0

Quick filters

184 trials in Ruse

Open in trial search

Colitis ulcerative

Not recruiting

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Etrasimod Arginine
Sponsor:Arena Pharmaceuticals Inc.

Contact Research Centre

Major depression

Not recruiting

Study on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder

Investigational

Study on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Nelivaptan
Sponsor:HMNC Holding GmbH

Contact Research Centre

Major depression

Not recruiting

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Aticaprant
Sponsor:Janssen Cilag International

Contact Research Centre

Major depression+1

Not recruiting

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Investigational

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Investigational

Bulgaria

Participants:18–64 years
Substances:Aticaprant
Sponsor:Janssen Cilag International

Contact Research Centre

Bipolar disorder

Not recruiting

Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

Investigational

Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Lumateperone
Sponsor:Intra-Cellular Therapies Inc.

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Investigational

Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Rifamycin Sodium
Sponsor:Cosmo Technologies Limited

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Budesonide
Sponsor:AstraZeneca AB

Contact Research Centre

Urinary tract infection

Not recruiting

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cilastatin
Sponsor:Spero Therapeutics Inc.

Contact Research Centre

Schizophrenia

Not recruiting

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Valbenazine Ditosylate
Sponsor:Neurocrine Biosciences Inc.

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Chronic cutaneous lupus erythematosus+2

Not recruiting

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Litifilimab
Sponsor:Biogen Idec Research Limited

Contact Research Centre

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Ruse

What the registry says about research in the country

01 Respiratory Diseases

Current clinical research focuses on asthma management and innovative treatments for respiratory conditions, including trials of new inhaler formulations and targeted therapies for uncontrolled asthma patients.

Asthma treatment optimization
Severe viral lung infections
Influenza prevention

Studies are evaluating both novel compounds and improved delivery systems for existing medications.

02 Cardiovascular Health

Breakthrough research in cardiovascular disease prevention and treatment, with particular attention to heart failure prevention and innovative approaches to managing cardiac conditions.

Heart failure prevention
Hypertrophic cardiomyopathy
Major cardiovascular events reduction

Multiple trials are exploring combination therapies and new molecular entities for cardiac conditions.

03 Immunology and Inflammation

Extensive research into psoriatic arthritis treatments, including both biologic-naive and biologic-experienced patient populations.

Psoriatic arthritis therapies
Prurigo nodularis treatment
Inflammatory conditions

Studies are evaluating novel therapeutic approaches for various inflammatory conditions.

Back to Bulgaria All countries